Caspofungin Versus Fluconazole in Preventing Invasive Fungal Infections (IFI) in Patients Undergoing Chemotherapy for Acute Myeloid Leukemia
Conditions
- Acute Myeloid Leukemia
- Adult Acute Monoblastic Leukemia
- Adult Acute Monocytic Leukemia
- Adult Acute Myeloid Leukemia in Remission
- Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11
- Adult Acute Myeloid Leukemia With Maturation
- Adult Acute Myeloid Leukemia With Minimal Differentiation
- Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11
- Adult Acute Myeloid Leukemia With t(8;21); (q22; q22.1); RUNX1-RUNX1T1
- Adult Acute Myeloid Leukemia With t(9;11)(p22.3;q23.3); MLLT3-KMT2A
- Adult Acute Myeloid Leukemia Without Maturation
- Adult Acute Myelomonocytic Leukemia
- Alkylating Agent-Related Acute Myeloid Leukemia
- Childhood Acute Monoblastic Leukemia
- Childhood Acute Monocytic Leukemia
- Childhood Acute Myeloid Leukemia in Remission
- Childhood Acute Myeloid Leukemia With Maturation
- Childhood Acute Myeloid Leukemia With Minimal Differentiation
- Childhood Acute Myeloid Leukemia Without Maturation
- Childhood Acute Myelomonocytic Leukemia
- Fungal Infection
- Myeloid Neoplasm
- Neutropenia
- Recurrent Adult Acute Myeloid Leukemia
- Recurrent Childhood Acute Myeloid Leukemia
- Secondary Acute Myeloid Leukemia
- Untreated Adult Acute Myeloid Leukemia
- Untreated Childhood Myeloid Neoplasm
Interventions
- DRUG: Caspofungin Acetate
- DRUG: Fluconazole
- OTHER: Laboratory Biomarker Analysis
Sponsor
Children's Oncology Group
Collaborators